Unknown OBSERVATIONAL NCT03624205

The Safety and Efficacy of SeQuent® Please in Real World Chinese Coronary Instent Restenosis Patients

To Evaluate the Long Term Safety and Efficacy of Drug Coated Balloon SeQuent® Please in Chinese Coronary Instent Restenosis Patients,a Prospective, Multi-center,Randomization Clinical Trial.

Sponsor: B. Braun Medical International Trading Company Ltd.

Conditions Coronary In Sentrestenosis

Interventions paclitaxel-releasing coronary balloon (SeQuent® Please)

Updated 5 times since 2018 Last updated: Aug 8, 2018 Started: Apr 24, 2015 Primary completion: Jan 1, 2022 Completion: Mar 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Coronary In Sentrestenosis, this trial is ongoing. The trial is conducted by B. Braun Medical International Trading Company Ltd. and has accumulated 5 data snapshots since 2015. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Apr 2022 — Jul 2024 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Apr 2022 [monthly]

Active Not Recruiting
Sep 2018 — Jan 2021 [monthly]

Active Not Recruiting

First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

B. Braun Medical International Trading Company Ltd.

Data source: B. Braun Medical International Trading Company Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.